HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bernard-Soulier syndrome: diagnosis by an ELISA method using monoclonal antibodies in 2 new unrelated patients.

Abstract
Two unrelated patients with Bernard-Soulier syndrome and their relatives were studied. The patients demonstrated severe bleeding diathesis, the relatives were asymptomatic. The propositi showed the characteristic abnormalities of the syndrome: thrombocytopenia, a percentage of giant platelets higher than 65%, prolonged bleeding time and defective platelet aggregation to ristocetin and bovine plasma. On the contrary, in the heterozygotes, the typical abnormalities were not fully evident. We introduce a simple ELISA method for the precise definition of both homozygous and heterozygous states for the syndrome by the quantitation of platelet glycoprotein (GP) Ib. Specific binding of monoclonal antibodies anti-platelet GPIb was performed both by direct binding of radioiodinated antibody and by ELISA. Comparable results were obtained. In fact, we demonstrated near absence of GPIb in the 2 propositi and about half the amount in the heterozygotes studied compared to normal platelets.
AuthorsL De Marco, F Fabris, A Casonato, P Fabris, M G Dal Ben, A Barbato, A Girolami
JournalActa haematologica (Acta Haematol) Vol. 75 Issue 4 Pg. 203-8 ( 1986) ISSN: 0001-5792 [Print] Switzerland
PMID3096050 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Platelet Membrane Glycoproteins
Topics
  • Adolescent
  • Antibodies, Monoclonal
  • Bernard-Soulier Syndrome (blood, diagnosis, genetics)
  • Blood Platelet Disorders (diagnosis)
  • Blood Platelets (analysis, immunology)
  • Child
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Genetic Carrier Screening
  • Homozygote
  • Humans
  • Male
  • Pedigree
  • Platelet Membrane Glycoproteins (analysis, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: